Cargando…

Managing Complexity: Exploring Decision Making on Medication by Young Adults with ADHD

Attention-deficit hyperactivity disorder (ADHD) causes difficulties with hyperactivity, impulsivity and inattention. Treatment of ADHD includes both medication and non-pharmacological options. Knowledge of treatment preferences by young adults with ADHD is sparse. The objective of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Druedahl, Louise C., Kälvemark Sporrong, Sofia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025481/
https://www.ncbi.nlm.nih.gov/pubmed/29671768
http://dx.doi.org/10.3390/pharmacy6020033
_version_ 1783336289959936000
author Druedahl, Louise C.
Kälvemark Sporrong, Sofia
author_facet Druedahl, Louise C.
Kälvemark Sporrong, Sofia
author_sort Druedahl, Louise C.
collection PubMed
description Attention-deficit hyperactivity disorder (ADHD) causes difficulties with hyperactivity, impulsivity and inattention. Treatment of ADHD includes both medication and non-pharmacological options. Knowledge of treatment preferences by young adults with ADHD is sparse. The objective of this study was to explore the beliefs and experiences of young adults with ADHD related to their medication treatment decisions. Data were collected in Denmark in 2016 through a focus group and individual in-depth interviews. Conventional content analysis was used. Ten young adults with ADHD (22-to 29-year-old) participated. Three major themes were identified: (1) the patient’s right to choose concerning ADHD medicine; (2) the patient’s decision of whether or not to treat ADHD with medication; and (3) factors affecting the patient’s decision on whether to take ADHD medication or not. The latter theme contained 15 factors, which were distributed across three levels: individual, between-individuals, and societal. The dominant factors were increasing quality of life and improving oneself e.g., improving social skills. For counselling at the pharmacy and by prescribers, it is important to be aware of the different factors that affect young adult patients’ decisions on whether to take ADHD medication or not. This knowledge will aid to understand reasons for non-adherence and to determine appropriate treatment for the individual patient.
format Online
Article
Text
id pubmed-6025481
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-60254812018-07-09 Managing Complexity: Exploring Decision Making on Medication by Young Adults with ADHD Druedahl, Louise C. Kälvemark Sporrong, Sofia Pharmacy (Basel) Article Attention-deficit hyperactivity disorder (ADHD) causes difficulties with hyperactivity, impulsivity and inattention. Treatment of ADHD includes both medication and non-pharmacological options. Knowledge of treatment preferences by young adults with ADHD is sparse. The objective of this study was to explore the beliefs and experiences of young adults with ADHD related to their medication treatment decisions. Data were collected in Denmark in 2016 through a focus group and individual in-depth interviews. Conventional content analysis was used. Ten young adults with ADHD (22-to 29-year-old) participated. Three major themes were identified: (1) the patient’s right to choose concerning ADHD medicine; (2) the patient’s decision of whether or not to treat ADHD with medication; and (3) factors affecting the patient’s decision on whether to take ADHD medication or not. The latter theme contained 15 factors, which were distributed across three levels: individual, between-individuals, and societal. The dominant factors were increasing quality of life and improving oneself e.g., improving social skills. For counselling at the pharmacy and by prescribers, it is important to be aware of the different factors that affect young adult patients’ decisions on whether to take ADHD medication or not. This knowledge will aid to understand reasons for non-adherence and to determine appropriate treatment for the individual patient. MDPI 2018-04-19 /pmc/articles/PMC6025481/ /pubmed/29671768 http://dx.doi.org/10.3390/pharmacy6020033 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Druedahl, Louise C.
Kälvemark Sporrong, Sofia
Managing Complexity: Exploring Decision Making on Medication by Young Adults with ADHD
title Managing Complexity: Exploring Decision Making on Medication by Young Adults with ADHD
title_full Managing Complexity: Exploring Decision Making on Medication by Young Adults with ADHD
title_fullStr Managing Complexity: Exploring Decision Making on Medication by Young Adults with ADHD
title_full_unstemmed Managing Complexity: Exploring Decision Making on Medication by Young Adults with ADHD
title_short Managing Complexity: Exploring Decision Making on Medication by Young Adults with ADHD
title_sort managing complexity: exploring decision making on medication by young adults with adhd
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025481/
https://www.ncbi.nlm.nih.gov/pubmed/29671768
http://dx.doi.org/10.3390/pharmacy6020033
work_keys_str_mv AT druedahllouisec managingcomplexityexploringdecisionmakingonmedicationbyyoungadultswithadhd
AT kalvemarksporrongsofia managingcomplexityexploringdecisionmakingonmedicationbyyoungadultswithadhd